Recordati Industria Chimica e Farmaceutica S.p.A. (REC)
MTA
Real-time Data
07:00 AM
Day's Range
52.7052 wk Range
43.76Overview - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
Key Statistics
Valuation
Enterprise Value
12.74B
P/E (Trailing)
‪22.16‬
P/E (Forward)
‪13.95‬
PEG Ratio
‪13.95‬
Price / Sales (TTM)
‪3.99‬
Price / Book
‪5.07‬
EV / EBITDA
‪12.56‬
Profitability
Gross Margin
‪71.40%‬
Profit Margin
‪18.37%‬
Operating Margin
‪29.19%‬
Return on Assets
‪9.77%‬
Return on Equity
‪24.85%‬
Ownership
Shares Outstanding
204.81M
Float
101.97M
Held by Insiders
‪46.82%‬
Held by Institutions
‪33.74%‬
Price stats
Beta
‪0.53‬
50-Day Avg
‪51.68‬
200-Day Avg
‪49.57‬
Dividends
Payout Ratio
‪56.29%‬
Frequency
Semi-Annual
Analyst Consensus
9 analysts
Average price target
‪€ 59.26‬Market Cap - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
Peers - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
Profile Summary - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
About
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical company specializing in the development, manufacturing, and commercialization of innovative medicines across specialty and primary care, consumer healthcare, and rare diseases. Headquartered in Milan, Italy, it traces its origins to a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
